Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2013 3
2014 4
2015 6
2016 7
2017 2
2018 2
2019 3
2020 6
2021 4
2022 7
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jiangyang zhang (147 results)?
A membrane-associated MHC-I inhibitory axis for cancer immune evasion.
Chen X, Lu Q, Zhou H, Liu J, Nadorp B, Lasry A, Sun Z, Lai B, Rona G, Zhang J, Cammer M, Wang K, Al-Santli W, Ciantra Z, Guo Q, You J, Sengupta D, Boukhris A, Zhang H, Liu C, Cresswell P, Dahia PLM, Pagano M, Aifantis I, Wang J. Chen X, et al. Among authors: zhang j. Cell. 2023 Aug 31;186(18):3903-3920.e21. doi: 10.1016/j.cell.2023.07.016. Epub 2023 Aug 8. Cell. 2023. PMID: 37557169 Free PMC article.
Recent advances in microRNA detection.
Cheng Y, Dong L, Zhang J, Zhao Y, Li Z. Cheng Y, et al. Among authors: zhang j. Analyst. 2018 Apr 16;143(8):1758-1774. doi: 10.1039/C7AN02001E. Analyst. 2018. PMID: 29560992 Review.
MicroRNAs regulate bone metabolism.
Zhao X, Xu D, Li Y, Zhang J, Liu T, Ji Y, Wang J, Zhou G, Xie X. Zhao X, et al. Among authors: zhang j. J Bone Miner Metab. 2014 May;32(3):221-31. doi: 10.1007/s00774-013-0537-7. Epub 2013 Dec 6. J Bone Miner Metab. 2014. PMID: 24311309 Review.
PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC.
Wang X, Li X, Wei X, Jiang H, Lan C, Yang S, Wang H, Yang Y, Tian C, Xu Z, Zhang J, Hao J, Ren H. Wang X, et al. Among authors: zhang j. Signal Transduct Target Ther. 2020 Apr 17;5(1):38. doi: 10.1038/s41392-020-0144-8. Signal Transduct Target Ther. 2020. PMID: 32300119 Free PMC article.
42 results